AzTrials
AzTrials

HypothermiaPREVINQ-WARMNCT03961620

Study on the Incidence of Perioperative Hypothermia at the Surgical Area of Parc Tauli Hospital Universitari, Sabadell

An observational study of Hypothermia, run by Corporacion Parc Tauli at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study TAULÍ-PREVINQ-WARM will assess the rate of perioperative hypothermia in patients submitted to major surgical procedures at the operating room main area (and at the ambulatory surgery building for ophthalmologic major procedures) of the Parc Taulí, Hospital Universitari, Sabadell, Barcelona. Read more about this study

Who is it for?
Ages 8 to 100 years
Conditions the study is for
Hypothermia
Type of treatment
Medical device
How many people
101 participants
Where
1 siteSpain
Study dates
9 Jul 2019to 22 Feb 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 100 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients submitted to elective major surgical procedures from different surgical specialties

Who may be able to join

  • ASA score I to IV
  • Patients submitted to major surgical procedures at the main OR facilities (or at the ambulatory surgery building for ophthalmologic procedures) under general or neuraxial anesthesia from surgical specialties
  • Patients (parents or legal guardians regarding pediatric patients) that have signed informed consent form.

Who cannot join

  • Patients submitted to craniofacial neurosurgical procedures
  • Patients submitted to any surgical procedure requiring draping or sterile isolation of the frontal part of head, precluding intraoperative assessment of SpotOn sensor.
  • Patients (parents or legal guardians regarding pediatric patients) that have not signed informed consent form.
  • Patients that by the time of the hospital admission present a relevant inflammatory or infectious process at the skin of frontal part of the head
  • Patients diagnosed with psychiatric disease relevant enough to avoid adequate staff-patients communication for this specific study

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Parc Tauli Hospital Universitari

    Sabadell, Barcelona, 08208

Other trials in Spain

About this study

Official title: Prospective Observational Study on the Incidence of Perioperative Hypothermia and the Effect of Standard Normothermia Measures at the Surgical Area of Parc Tauli Hospital Universitari, Sabadell: Tauli-Previnq-Warm

The study TAULÍ-PREVINQ-WARM will assess the rate of perioperative hypothermia in patients submitted to major surgical procedures at the operating room main area (and at the ambulatory surgery building for ophthalmologic major procedures) of the Parc Taulí, Hospital Universitari, Sabadell, Barcelona.

Read the detailed description

Treatment plan The month before the start of the study, investigators will double check with the administrative personnel the potential candidates to be included in to the study. Furthermore, investigators will meet with the responsible of each surgical specialty to delineate the adequate staff workload and collaborators needs. To assure the best study performance and to avoid selection patient bias, patients will be consecutively included in blocs of each designated surgical specialty.

At the patient admission area and surgical preparation, associated investigators will inform to candidates and relatives about the project giving the informed form to be signed.

Patient inclusion will include a pilot phase (four to five patients) to teach collaborators regarding the correct placement of cutaneous sensor, data lecture and registration to the database. Along with the maintenance department of the hospital, we also assess the correct installation and function of temperature and humidity sensors at the OR (Mini-datalogger 174H, Instrumentos Testo, S.A. Cabrils, Barcelona). OR temperature and the degree of humidity will be measured at the specific time points stated at the paragraph of the measurements.

Body temperature (BT) measurements will be performed at the UPQ, anesthesia preparation room, OR and URPA in those specifically stated time points (Annex 2 and Figure 1).

Because the investigators want to perform a pragmatic study, patients will receive conventional normothermia preventive measures following the approved local guidelines from the Anesthesiology Department.

Measurement and data entry Body temperature (BT) Patient's BT will be assessed with the SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit.

Non-invasive digital BT system monitorization SpotOn, includes a sensor that by adhering to the lateral side of supra-ocular region, allows for continued registration of BT for the overall surgical process.

Number of times and sites of BT registration Staff devoted to assess BT measurements. Staff from 3M, will advise nurses, anesthesiologists and investigators regarding SpotOn specifications and management at the beginning of the study

Because OR temperature and degree of humidity may have some influence on patient's BT and thermic comfort both patients and OR staff, OR temperature and humidity will be registered at the beginning and at the end of surgical procedure. Also, the protocol will take in to the account weather conditions registered at the MeteoCat and will be included at the data base regularly. Also, staff from Maintenance of Hospital Facilities and Equipment, will set up and store data from the OR temperature and humidity sensors (Mini-datalogger 174H, Instrumentos Testo, S.A. Cabrils, Barcelona).

Data about measures addressed to sustain perioperative normothermia will also be recorded (see Annex 4)

At the end of surgical procedure the investigators will ask patients and OR staff for running a visual analogic scale punctuation (1 to 10) regarding the perceived thermal comfort (see Annex 5)

Length of the study and period of patients recruitment. Because the specific nature of this prospective observational and pragmatic study, the rate of patients recruitment will be assessed frequently to accommodate both optimal patient accrual and fair and adequate entry data. The approximate time for total patients inclusion will be of one year.

Sample size The main objective of the study TAULI-PREVINQ-WARM is to assess the rate of perioperative hypothermia (<36ªC) at some point during the surgical process in patients operated on for a major surgical procedure at the Parc Tauli, Hospital Universitari, Sabadell. Then, sample size has been calculated taking in to the account that roughly 50% of patients will have some kind of hypothermia with 10% of variability of 95% CI. Assuming a10% of repository additional patients, 110 patients will be included overall.

Assessment of data results and statistical analysis. The TAULI-PREVINQ-WARM is a pragmatic study that wants to assess body temperature in surgical patients under regular clinical conditions. We will perform a descriptive analysis of data by depicting mainly frequency distribution analysis of the qualitative main variable, HypoTer. The proposed sample size will allow also for assessing the rate HypoTer at each different surgical areas where patients are admitted. Also, repeated measures will be compared among different surgical procedures at the OR taking in to consideration the body surface area under regular preventive normothermia measures, following the general lineal model. Univariate two-sided analysis will be perform for all comparisons and parametric or non-parametric analysis will be performed accordingly. Multivariate analysis might eventually be performed depending of the rate of events.

Conditions
Hypothermia
Being tested
The SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit.
Keywords
perioperative hypothermia, core temperature, perioperative normothermia
Medical subject headings
Hypothermia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit.Device

    Patients submitted to major surgical procedure will be assessed for core body temperature by employing SpotOn sensor device, before, during and after surgical procedure.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of perioperative hypothermia (<36ºC)

    Body temperature measured by SpotOn system sensor in different surgical procedures and at any specific surgical area.

    Measured: 12 hours

Secondary outcomes (4)
  1. Type and duration of applied physical measures to prevent periopertive hypothermia

    The investigators will corroborate whether or not textile blankets, forced air warming blankets or additional measures are applied, anf if so, the time and durations of such measures.

    Measured: 12 hours

  2. Temperature at the operating room

    Temperature and degree of humidity at the OR

    Measured: 1-6 hours

  3. Thermal confort

    Thermal comfort of patients and OR staff members

    Measured: 1-6 hours

  4. Adverse events

    Rate of postoperative adverse events

    Measured: Up to 30 days (1 year for prosthetic surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2019
  2. Study start9 Jul 2019
  3. Primary completion30 Dec 2021
  4. Study completion22 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03961620
Sponsor's protocol ID
2018/630
Acronym
PREVINQ-WARM
Status last verified
Aug 2022
First submitted
21 May 2019
Last updated
3 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hypothermia, run by Corporacion Parc Tauli at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of perioperative hypothermia (<36ºC) (time frame: 12 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in